Retinal Surgery Market To Worth USD 4.16 Billion By 2032 - SNS Insider
SNS Insider Reports: Retinal Surgery market to Grow at 6.05% CAGR, Fueled by Minimally Invasive Tools, Aging Population & Increasing diabetic Retinopathy Cases ...
Atsena Therapeutics to Present ATSN-201 Safety and Efficacy Data at The Macula Society’s 48th Annual Meeting
Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...
Astellas Pharma Inc.: U.S. FDA Approves Expanded Label for Astellas' IZERVAY (avacincaptad pegol intravitreal solution) for Geographic Atrophy
IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...
ophthalmologytimes12d
Gene therapy voretigene neparvovec boosts vision in pediatric IRD patients
Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated ...
The Punch Newspapers28d
Sickle cell and eye problems
These fragile new vessels can rupture, causing bleeding, scarring, and retinal detachment ... cells can impair circulation in the choroid, a layer of blood vessels that nourishes the outer ...
shawlocal9d
The Link Between Retinal Health and Overall Wellness
The retina, a thin layer of tissue at the back of the eye ... Common retinal conditions include diabetic retinopathy, macular degeneration, and retinal detachment. Early detection and treatment are ...
bjo.bmj4d
Recovery of photoreceptor inner and outer segment layer thickness after reattachment of rhegmatogenous retinal detachment
layers after a reattachment of a rhegmatogenous retinal detachment (RRD). Methods 49 eyes of 49 patients (mean age, 57.4±10.3 years) with successfully reattached RRD were retrospectively studied.